INTRIGUE: A phase III, randomized, open-label study to evaluate the efficacy and safety of ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib

Heinrich, Michael C. ; Jones, Robin Lewis ; Gelderblom, Hans ; George, Suzanne ; Schöffski, Patrick ; von Mehren, Margaret ; Zalcberg, John Raymond ; Kang, Yoon-Koo ; Abdul Razak, Albiruni Ryan ; Trent, Jonathan C. ; Attia, Steven ; Le Cesne, Axel ; Su, Ying ; Meade, Julie Nicole ; Wang, Tao ; Sherman, Matthew L. ; Ruiz-Soto, Rodrigo ; Blay, Jean-Yves ; Bauer, Sebastian

Journal of clinical oncology, 2022, Vol.40 (36_suppl), p.359881-359881 [Periódico revisado por pares]

Texto completo disponível